Data on PV-10 combination therapy presented at AACR Annual Meeting

[News]

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, presented data on PV-10 combination therapy today at the American Association for Cancer Research Annual Meeting in Washington, DC.

More... (http://www.news-medical.net/news/20130411/Data-on-PV-10-combination-therapy-presented-at-AACR-Annual-Meeting.aspx)